dagrocorat dagrocorat dagrocorat (developmental code names pf-00251802, pf-251802) is a nonsteroidal but steroid-like selective glucocorticoid receptor modulator (sgrm) which was under development for the treatment of rheumatoid arthritis but was never marketed. it is described as a partial agonist and "dissociable" agonist of the glucocorticoid receptor. the drug reached phase i clinical trials prior to the discontinuation of its development. the c2α dihydrogen phosphate ester of dagrocorat, fosdagrocorat, was also under investigation, but its development was terminated as well. dagrocoratclinical dataother namespf-00251802; pf-251802drug classselective glucocorticoid receptor modulatoridentifiers iupac name (4bs,7r,8ar)-4b-benzyl-7-hydroxy-n-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-5,6,8,8a,9,10-hexahydrophenanthrene-2-carboxamide cas number1044535-52-5pubchem cid24873449chemspider32700623uniiopm23un90ukeggd10617chemblchembl3137304comptox dashboard (epa)dtxsid60146493 chemical and physical dataformulac29h29f3n2o2molar mass494.558 g·mol−13d model (jsmol)interactive image smiles cc1=c(c=cc=n1)nc(=o)c2=cc3=c(c=c2)4(cc(c4cc3)(c(f)(f)f)o)cc5=cc=cc=c5 inchi inchi=1s/c29h29f3n2o2/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(36,29(30,31)32)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23,36h,9,11,13-14,17-18h2,1h3,(h,34,35)/t23-,27+,28-/m1/s1key:qjjbnchswfgxml-kekpkeolsa-n